Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

Boston Scientific stock is up as company officials predict that the ongoing trade war won't hinder double-digit sales growth ...

In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

Baird analyst David Rescott maintained Boston Scientific with an Outperform rating and raised the price target from $115 to $120. Evercore ISI Group analyst Vijay Kumar maintained the stock with an ...

Raymond James lowered the firm’s price target on Boston Scientific (BSX) to $121 from $122 and keeps a Strong Buy rating on the shares. Boston ...

Truist analyst Richard Newitter raised the firm’s price target on Boston Scientific (BSX) to $117 from $113 and keeps a Buy rating on the ...